MOTS-c

peptideresearch peptide

Research chemical — not an approved drug or dietary supplement

This compound is sold for research and is not FDA-approved for human use or as a dietary supplement. Human evidence is limited; purity and dosing of consumer products are unverified. The data below is an evidence review for education only — talk to a clinician before considering it.

At a glance

Best for
Not established — investigational
Main caution
Entirely preclinical evidence; unapproved research chemical of unknown purity and human safety
Evidence strength: Preclinical/animal only; no approved human use

What is it

MOTS-c is a mitochondrial-derived peptide (encoded within the mitochondrial 12S rRNA region) that has drawn research interest as a regulator of metabolic homeostasis, proposed to influence AMPK signaling, insulin sensitivity, and exercise capacity. The evidence is essentially all preclinicalcell and rodent studiesand there are no established controlled human clinical trials demonstrating the safety or efficacy of the marketed 'research' peptide. It is not FDA-approved, is not a dietary supplement, and is sold only 'for research use only.'

Is it worth it for you?

Probably skip if…

  • You expect a proven metabolic or performance therapy — it is neither FDA-approved nor a supplement
  • You would source it from 'research use only' vendors with no purity or sterility controls
  • You are not prepared for completely unknown human safety, as no controlled trials exist
  • You are uncomfortable with self-injection risks such as infection and contamination
  • You compete in sport — novel metabolic/performance peptides can fall under anti-doping prohibitions

Safety

Common side effects

Not well characterized in humans — no controlled trials define a side-effect profile

Serious risks

  • Unregulated purity, sterility, and dosing of research-grade product
  • Unknown long-term effects of administering a mitochondrial-derived peptide in humans
  • Injection-related infection and contamination risk
  • No clinical monitoring of metabolic markers

Who should avoid it

  • Anyone using it without direct medical supervision
  • Pregnancy and breastfeeding
  • People with metabolic or endocrine disorders (without supervision)
  • Competitive athletes subject to anti-doping rules

Pregnancy & breastfeeding

Avoid — no safety data.

Choosing a product

Be skeptical of

  • 'Proven' metabolic, fat-loss, anti-aging, or exercise-performance claims in humans
  • Vendors selling 'for research use only' product for human injection
  • 'Exercise in a vial' or similar overhyped marketing

Track MOTS-c with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: This compound is not approved by the FDA for human use and is not a dietary supplement. This page is an educational review of available research — much of it preclinical or early-stage — not a recommendation to use it. Consumer product quality is unregulated. Consult a qualified clinician.